NCT06799351 2025-02-12
OzoParQTmicrob
Dr. Negrin University Hospital
Phase 2/3 Recruiting
Clinical Trials
8 trialsNCT06706544 2025-02-11
OzoParQT
Dr. Negrin University Hospital
Phase 2/3 Recruiting
NCT03875833 2023-05-22
Prospective Analysis of Effect of Collagen Wrap Conduit on Radial and Ulnar Nerve Function Following Radial/Ulnar Forearm Free Flap Harvest
The University of Texas Health Science Center, Houston
Phase NA Withdrawn
NCT00039780 2022-07-13
Evaluation of BNP7787 for the Prevention of Neurotoxicity in Metastatic Breast Cancer Patients Receiving Weekly Paclitaxel
BioNumerik Pharmaceuticals, Inc.
Phase 3 Completed
NCT03206216 2018-12-19
Feasibility Study of New Method of Diagnostic and Prediction of Painful CIPN
Stanford University
Phase NA Terminated
NCT01775449 2017-07-11
NEUROXAPOL
University Hospital, Clermont-Ferrand
Phase 3 Completed
NCT00305188 2016-05-04
Evaluation of the Efficacy of Xaliproden (SR57746A) in Preventing the Neurotoxicity of Oxaliplatin / 5FU/LV Chemotherapy.
Sanofi
Phase 3 Completed
NCT00272051 2006-09-13
XENOX - Evaluation of the Efficacy of Xaliproden in Reducing the Neurotoxicity of the Oxaliplatin + 5-FU/LV Chemotherapy
Sanofi
Phase 3 Completed